DANAHER CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 256.8 USD | +1.61% |
|
-2.28% | +11.01% |
| 29/05 | Agilent lowers full-year revenue forecast on slowing demand from its biotech clients | RE |
| 23/05 | Some of the biggest splits in Corporate America | RE |
| Sales 2024 * | 23.88B 1,992B | Sales 2025 * | 25.99B 2,168B | Capitalization | 190B 15,866B |
|---|---|---|---|---|---|
| Net income 2024 * | 4.42B 369B | Net income 2025 * | 5.33B 444B | EV / Sales 2024 * | 8.31 x |
| Net Debt 2024 * | 8.38B 699B | Net Debt 2025 * | 2.7B 225B | EV / Sales 2025 * | 7.42 x |
| P/E ratio 2024 * |
43.4
x | P/E ratio 2025 * |
35.6
x | Employees | 62,000 |
| Yield 2024 * |
0.42% | Yield 2025 * |
0.45% | Free-Float | 74.91% |
More Fundamentals
* Assessed data
More news
Latest transcript on Danaher Corporation
More recommendations
More press releases
More news
| 1 day | +1.61% | ||
| 1 week | -2.28% | ||
| 1 month | +4.13% | ||
| 3 months | +1.45% | ||
| 6 months | +15.00% | ||
| Current year | +11.01% |
1 week
248.53
263.81
1 month
242.66268.98
Current year
222.53268.98
1 year
182.09269.61
3 years
182.09333.96
5 years
119.60333.96
10 years
70.12333.96
| Managers | Title | Age | Since |
|---|---|---|---|
Rainer Blair
CEO | Chief Executive Officer | 60 | 01/10/01 |
Steven Rales
FOU | Founder | 72 | 01/83/01 |
Mitchell Rales
FOU | Founder | 67 | 01/83/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Mitchell Rales
FOU | Founder | 67 | 01/83/01 |
Alan Spoon
BRD | Director/Board Member | 72 | 01/99/01 |
Steven Rales
FOU | Founder | 72 | 01/83/01 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 5.99% | 17 M€ | +6.09% | - | |
| 3.77% | 2 M€ | +2.32% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/24/31 | 256.8 | +1.61% | 4,801,089 |
| 30/24/30 | 252.7 | -1.25% | 3,450,877 |
| 29/24/29 | 255.9 | -1.07% | 2,931,704 |
| 28/24/28 | 258.7 | -1.55% | 2,881,256 |
| 24/24/24 | 262.8 | +0.53% | 2,089,037 |
Delayed Quote Nyse, May 01, 2024 at 01:35 am IST
More quotes
Danaher Corporation is an industrial and technologic group organized around two families of products:
- medical equipment (70.1% of net sales): diagnostic equipment, digital imaging systems, optical instruments, microscopes, consumables, etc.;
- professional instruments of analysis (29.9%): systems of quality control of waters, disinfection, etc.
Net sales are distributed geographically as follows: the United States (40.1%), China (13.2%) and other (46.7%).
Calendar
28/06/2024
- Ex-dividend day
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
256.8
USD
Average target price
272.7
USD
Spread / Average Target
+6.18%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +11.01% | 190B | |
| +7.01% | 217B | |
| +19.20% | 143B | |
| +30.79% | 111B | |
| +1.48% | 64.59B | |
| +13.95% | 52.36B | |
| -0.16% | 48.45B | |
| -6.20% | 38.03B | |
| +0.91% | 35.61B | |
| +19.95% | 30.31B |
- Stock Market
- Equities
- DHR Stock
